NCT06217536View on ClinicalTrials.gov

Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas

PHASE1/PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 31, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

October 31, 2027

Conditions

Locally Advanced Soft Tissue Sarcoma

Interventions

DRUG

Lurbinectedin

Given intravenously (IV)

RADIATION

Radiotherapy

Conventionally fractionated radiotherapy or external beam radiation

PROCEDURE

Non-investigational surgery

Non-investigational surgical procedure on tumor tissue

Sponsors

Collaborators (1)

Jazz Pharmaceuticals

All Listed Sponsors

collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

University of California, San Francisco

OTHER